Glycemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with type 2 diabetes

被引：0
|
作者：
Dailey, G
Rosenstock, J
Moses, R
Ways, K
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [21] COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN
    Sellam, Y.
    Belhadj, M.
    Brouri, M.
    Haddam, A. E. M.
    Malek, R.
    Semrouni, M.
    Zekri, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S583 - S583
  • [22] The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Castellano E.
    Attanasio R.
    Giagulli V.A.
    Boriano A.
    Terzolo M.
    Papini E.
    Guastamacchia E.
    Monti S.
    Aglialoro A.
    Agrimi D.
    Ansaldi E.
    Babini A.C.
    Blatto A.
    Brancato D.
    Casile C.
    Cassibba S.
    Crescenti C.
    De Feo M.L.
    Del Prete A.
    Disoteo O.
    Ermetici F.
    Fiore V.
    Fusco A.
    Gioia D.
    Grassi A.
    Gullo D.
    Lo Pomo F.
    Miceli A.
    Nizzoli M.
    Pellegrino M.
    Pirali B.
    Santini C.
    Settembrini S.
    Tortato E.
    Triggiani V.
    Vacirca A.
    Borretta G.
    [J]. Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 393 - 399
  • [23] Efficacy and safety of post-meal insulin glulisine (GLU) compared with pre-meal regular human insulin (RHI) in a basal-bolus regimen with insulin glargine
    Garg, S
    Rosenstock, J
    Ways, K
    [J]. DIABETES, 2004, 53 : A125 - A125
  • [24] Efficacy and safety of insulin glulisine (GLU) versus insulin lispro (LIS) as part of a basal-bolus insulin regimen in children and adolescents with Type 1 diabetes (T1DM)
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [25] A basal-bolus regimen of insulin glargine and insulin glulisine results in a lower rate of hypoglycaemia relative to endpoint HbA1c versus twice-daily premixed insulin in type 2 diabetes patients
    Fritsche, A.
    Larbig, M.
    Haering, H. -U.
    [J]. DIABETOLOGIA, 2010, 53
  • [26] Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
    Efremova, N. V.
    Bolotskaya, L. L.
    Atarshchikov, D. S.
    Bondarenko, O. N.
    Ilyin, A. V.
    Shestakova, M. V.
    [J]. TERAPEVTICHESKII ARKHIV, 2015, 87 (10): : 42 - 49
  • [27] Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
    Vague, P
    Selam, JL
    Skeie, S
    De Leeuw, I
    Elte, JWF
    Haahr, H
    Kristensen, A
    Draeger, E
    [J]. DIABETES CARE, 2003, 26 (03) : 590 - 596
  • [28] Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
    Ruhnau, Klaus-Juergen
    [J]. DIABETES, 2006, 55 : A479 - A479
  • [29] Switching from an NPH Insulin to an Insulin Glargine Basal-Bolus Regimen Improves Glycemic Control in Diabetic Patients: The LINDA Study
    Kvapil, Milan
    Krivska, Bohumila
    Avy, Zdenek Ru
    [J]. DIABETES, 2011, 60 : A621 - A621
  • [30] Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
    Vellanki, Priyathama
    Cardona, Saumeth
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Pasquel, Francisco J.
    Davis, Georgia M.
    Fayfman, Maya
    Migdal, Alexandra
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2022, 45 (10) : 2217 - 2223
12345